Abstract
Get full access to this article
View all access options for this article.
References
1.
Merck
KGaA
.
Merck
KGaA
,
Darmstadt
Germany Announces Boost to Commercial Viral Vector and Gene Therapy Manufacturing Capacity
. April 21, 2020. https://www.emdgroup.com/en/news/boost-to-viral-vector-gene-therapy-manufacturing-21-04-2020.html (last accessed
April 28 , 2020
).
2.
Asklepios
BioPharmaceutical
.
AskBio Acquires BrainVectis to Expand its Clinical Pipeline for Neurodegenerative
Diseases
. April 22, 2020. https://www.askbio.com/askbio-acquires-brainvectis-to-expand-its-clinical-pipeline-for-neurodegenerative-diseases/ (last accessed
April 28 , 2020
).
3.Fujifilm Diosynth Biotechnologies. FUJIFILM Diosynth Biotechnologies Enters Strategic Partnership With OXGENE™ To Address Supply Bottlenecks In Gene Therapy Development And Manufacturing . https://www.biospace.com/article/releases/fujifilm-diosynth-biotechnologies-enters-strategic-partnership-with-oxgene-to-address-supply-bottlenecks-in-gene-therapy-development-and-manufacturing/ (last accessed
April 18 , 2020
).
4.Evotec and Takeda Pharmaceutical. Evotec and Takeda enter into multi-year gene therapy research alliance . https://www.evotec.com/en/invest/news—announcements/p/evotec-and-takeda-enter-into-multi-year-gene-therapy-research-alliance-5925 (last accessed
April 28 , 2020
)
5.
MK
News
.
Kolon Life Sciences launches first pipeline in the
US
. www.mk.co.kr/news/it/view/2020/04/435069/ (last accessed
April 28 , 2020
)
6.Orchard Therapeutics. Orchard Therapeutics Announces First Patient Dosed with OTL-201 Gene Therapy in Proof-of-Concept Clinical Trial for Sanfilippo Syndrome (MPS-IIIA) . https://www.globenewswire.com/news-release/2020/04/27/2022315/0/en/Orchard-Therapeutics-Announces-First-Patient-Dosed-with-OTL-201-Gene-Therapy-in-Proof-of-Concept-Clinical-Trial-for-Sanfilippo-Syndrome-MPS-IIIA.html (last accessed
April 28 , 2020
)